Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Oxagen
Oxagen
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Oxagen
Total Funding
$130.6 M
Revenue
£24.2 K
FY, 2015
Oxagen Summary
Company Summary
Overview
Oxagen is a biopharmaceutical company that provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases.
Type
Private
Status
Active
Founded
1997
HQ
Abingdon, GB
|
view all locations
Website
http://www.oxagen.co.uk/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
pharma
Homepage
Linkedin
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Timothy Edwards,
Non-Executive Chairman
Regina Hodits,
Non-Executive Director
Locations
View all
1 location detected
Abingdon
HQ
United Kingdom
99 Park Dr
Oxagen Financials
Summary Financials
Revenue (FY, 2015)
£24.2K
Net income (FY, 2015)
(£251.1K)
Cash (FY, 2018)
£62.9K
EBIT (FY, 2015)
(£291.7K)
Competitors and Similar Companies
Genentech
Healthcare - Subsidiary
Livzon Pharmaceutical Group
Healthcare - Public
Mankind Pharma
Healthcare - Private
EMS Pharma
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top